Billetta R, Hollingdale M R, Zanetti M
Department of Medicine, University of California, San Diego 92103.
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4713-7. doi: 10.1073/pnas.88.11.4713.
We engineered an antibody expressing in the third complementarity-determining region of its heavy chain variable region a "foreign" epitope, the repetitive tetrapeptide Asn-Ala-Asn-Pro (NANP) of the circumsporozoite protein of Plasmodium falciparum parasite, one of the etiologic agents of malaria in humans. A monoclonal antibody to P. falciparum specific for the (NANP)n amino acid sequence bound to the engineered antibody, and a synthetic (NANP)3 peptide blocked this interaction. Immunization of rabbits and mice with the engineered antibody resulted in the elicitation of a humoral response to (NANP)3 synthetic peptide and P. falciparum parasite. In mice, in which immunity to the (NANP)n epitope is highly restricted by immune response genes, antibodies were induced in responder and nonresponder haplotypes of the major histocompatibility complex. Rabbit antibodies efficiently inhibited the in vitro invasion of cultured liver cells by P. falciparum parasite. Collectively, this study indicates that immunity to malaria in the absence of the parasite can be induced using antibody variable regions engineered to mimic the parasite's molecular structure. In general terms, the results suggest that antibody (idiotype) mimicry of an exogenous antigen is possible and may only require a discrete stretch of identity between the two molecules. The implication for the preparation of antibody-based vaccines and idiotype regulation of immunity are discussed.
我们构建了一种抗体,该抗体在其重链可变区的第三个互补决定区表达一个“外来”表位,即恶性疟原虫(人类疟疾的病原体之一)环子孢子蛋白的重复四肽天冬酰胺-丙氨酸-天冬酰胺-脯氨酸(NANP)。一种针对(NANP)n氨基酸序列的恶性疟原虫单克隆抗体与该构建抗体结合,并且一种合成的(NANP)3肽阻断了这种相互作用。用该构建抗体免疫兔和小鼠,引发了对(NANP)3合成肽和恶性疟原虫的体液反应。在对(NANP)n表位的免疫高度受免疫反应基因限制的小鼠中,主要组织相容性复合体的反应性和非反应性单倍型均诱导产生了抗体。兔抗体有效抑制了恶性疟原虫对培养肝细胞的体外侵袭。总体而言,本研究表明,使用经工程改造以模拟寄生虫分子结构的抗体可变区,可以在没有寄生虫的情况下诱导对疟疾的免疫。一般来说,结果表明对外源抗原的抗体(独特型)模拟是可能的,并且可能只需要两个分子之间有一段离散的相同序列。文中还讨论了基于抗体的疫苗制备及免疫独特型调节的意义。